We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Using Diagnostic Tools to Stage Breast Cancer

This study is ongoing, but not recruiting participants.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00367666
First Posted: August 23, 2006
Last Update Posted: September 18, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
University of Pennsylvania
  Purpose
This project is aimed at investigating the relative diagnostic and synergy of four state of the art breast imaging techniques (magnetic resonance imaging (MRI), full-field digital mammography (DMAM), ultrasound, and positron emission tomography (PET)) with respect to determining the extent of breast cancer.

Condition Intervention
Breast Cancer Device: MRI, Digital Mammography, Ultrasound and Positron Emission Tomography (PET)

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: Evaluation of Multimodality Breast Imaging: Lesion Staging

Resource links provided by NLM:


Further study details as provided by University of Pennsylvania:

Estimated Enrollment: 400
Actual Study Start Date: March 2002
Estimated Study Completion Date: August 1, 2020
Estimated Primary Completion Date: August 1, 2020 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Patients Diagnosed with Breast Cancer Device: MRI, Digital Mammography, Ultrasound and Positron Emission Tomography (PET)

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Women recently diagnosed with Breast Cancer
  • Will be undergoing surgery (after study) at the Hospital of the University of Pennsylvania

Exclusion Criteria:

  • Contraindications to MRI
  • previously diagnosed with breast cancer (in the smae breast) within the past 5 years
  • Patients with known locally advanced cancer (prior to study entry) being treated with preoperative adjuvant therapy.
  • Pregnant women
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00367666


Locations
United States, Pennsylvania
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104
Sponsors and Collaborators
University of Pennsylvania
Investigators
Principal Investigator: Abass Alavi, MD University of Pennsylvania
  More Information

Responsible Party: University of Pennsylvania
ClinicalTrials.gov Identifier: NCT00367666     History of Changes
Other Study ID Numbers: Protocol 414500
NIH funded
First Submitted: August 22, 2006
First Posted: August 23, 2006
Last Update Posted: September 18, 2017
Last Verified: September 2017

Additional relevant MeSH terms:
Breast Neoplasms
Neoplasms by Site
Neoplasms
Breast Diseases
Skin Diseases